Three independent discounted-cash-flow-style models value Edwards Lifesciences Corporation every trading day. 0 of 3 currently price EW above its market price.
| Free Cash Flow model | $39.10 |
| Excess Profit model | $48.12 |
| Residual Earnings model | $33.79 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +11.7% |
| Net debt / EBITDA | -1.3× |
| Gross margin | +78.0% |
| Revenue CAGR | +10.8% |
| Cash conversion | 1.5× |
| Dividend yield | — |
| Buyback yield | +1.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open EW in StockKitty